Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) issued an update on its FY 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.840-0.840 for the period. The company issued revenue guidance of $12.0 billion-$12.0 billion.
Daiichi Sankyo Trading Up 2.0 %
OTCMKTS:DSNKY traded up $0.55 during mid-day trading on Friday, hitting $28.66. The company had a trading volume of 246,773 shares, compared to its average volume of 192,069. The business’s fifty day moving average is $28.50 and its two-hundred day moving average is $33.03. Daiichi Sankyo has a fifty-two week low of $25.11 and a fifty-two week high of $42.48.
Daiichi Sankyo (OTCMKTS:DSNKY – Get Free Report) last released its quarterly earnings data on Friday, January 31st. The company reported $0.22 EPS for the quarter.
Daiichi Sankyo Company Profile
Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.
Further Reading
- Five stocks we like better than Daiichi Sankyo
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Best Way to Invest in Gold Is…
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Nike Stock Could Be 2025’s Top Comeback Play
- Stock Sentiment Analysis: How it Works
- Uber Stock Gaining Speed: Analysts See 30% Upside
Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.
